Vertex stock downgraded amid valuation high and pain franchise headwinds By Investing.com
© Reuters. On Tuesday, Vertex Prescribed drugs (NASDAQ:) Included (NASDAQ:VRTX) obtained a ranking downgrade from Evercore ISI, shifting from "Outperform" ...
© Reuters. On Tuesday, Vertex Prescribed drugs (NASDAQ:) Included (NASDAQ:VRTX) obtained a ranking downgrade from Evercore ISI, shifting from "Outperform" ...
© Reuters. Discover Wall Road's professional insights with this ProResearch article, which can solely be obtainable to InvestingPro subscribers quickly. ...
Healthcare firm Vertex Prescribed drugs Integrated (NASDAQ: VRTX) on Monday reported a rise in revenues for the third quarter of 2023. ...
Copyright © 2023 Money Wise Inc.
Money Wise Inc is not responsible for the content of external sites.